TY - CHAP M1 - Book, Section TI - Osteoarthritis Medication Therapy Management Data Set A1 - Dietrich, Eric A2 - Angaran, David M. A2 - Whalen, Karen Y1 - 2015 N1 - T2 - Medication Therapy Management: A Comprehensive Approach AB - Treatment goals for osteoarthritis should be identified prior to beginning treatment and individualized to the patient, with the goal of achieving an acceptable balance between minimizing pain and side effects as well as maximizing functionality along with quality of life.Optimal treatment of osteoarthritis includes both pharmacologic and nonpharmacologic therapies. Adherence to both should be assessed at each MTM encounter.Given the significant adverse effects of long-term NSAID treatment, reassessment of cardiovascular risk and GI bleeding risk should be conducted during each MTM encounter to ensure safety of continued treatment and the potential need for additional medications to reduce risk (eg, proton-pump inhibitors for GI bleeding risk).Assessment of potential adverse effects from analgesic therapy should be determined during each MTM encounter. Importantly, bleeding from NSAIDs and constipation, sedation, or respiratory depression associated with opioids should be monitored frequently. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1102489459 ER -